Tower Research Capital (TRC)’s Intercure INCR Stock Holding History
Bought
Maintained
Sold
Other funds holding INCR
II
AI
IEFM
Tower Research Capital (TRC)'s INCR Position: Q4 2022 in Review
Tower Research Capital (TRC) sold out of Intercure (INCR) in Q4 2022, closing a stake of 744 shares — an estimated $3K sold.
Tower Research Capital (TRC) first reported a position in INCR in Q2 2022 and held it in 2 quarters. The position peaked at $7K in Q2 2022. 15 funds tracked by Wall St. Rank hold INCR as of Q4 2022.
- Tower Research Capital (TRC) reported no remaining Intercure position as of Q4 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 744 Intercure shares in Q4 2022, an estimated $3K.
- Tower Research Capital (TRC) first reported a position in Intercure in Q2 2022 and held it in 2 quarters.
- Tower Research Capital (TRC)'s Intercure position peaked at $7K in Q2 2022.
- 15 funds tracked by Wall St. Rank held Intercure as of Q4 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.